| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/18/2010 | US20100040578 Malignant Tumor Cell Suppressor Protein, Malignant Tumor Cell Suppressor Gene, Maligant Tumor Cell Suppressive Viral Vector, and Kit Using the Same |
| 02/18/2010 | US20100040539 Vector System |
| 02/18/2010 | CA2733930A1 Anti-arrhythmia agents, methods of their use, methods of their identification, and kits therefore |
| 02/18/2010 | CA2732809A1 Aptamer inhibition of thrombus formation |
| 02/17/2010 | EP2153847A1 Gene sensitive to bone/joint disease and use thereof |
| 02/17/2010 | EP2153846A1 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immonostimulatory molecule |
| 02/17/2010 | EP2153820A1 Liposome and method for producing liposome |
| 02/17/2010 | EP2152317A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 02/17/2010 | EP1799748B1 Biodegradable cationic polymers |
| 02/17/2010 | EP1578919B1 Endogenous retrovirus up-regulated in prostate cancer |
| 02/17/2010 | EP1537227B1 Method for efficient rna interference in mammalian cells |
| 02/17/2010 | EP1490013B1 Methods for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising hydroxyurea |
| 02/17/2010 | EP1263954B1 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/17/2010 | EP1240186B1 Improvements in or relating to immune responses to hiv |
| 02/17/2010 | EP1200132B2 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 02/17/2010 | CN100590131C Methods and compounds for the targeting of protein to exosomes |
| 02/17/2010 | CN100589847C Boactivity peptide gene therapy plasmid carrier realized by propeptide recombination |
| 02/17/2010 | CN100589846C Boactivity peptide gene therapy method realized by propeptide recombination |
| 02/17/2010 | CN100589845C Anti-neovasculature preparations for cancer |
| 02/16/2010 | US7662949 Immunostimulatory oligoribonucleotides |
| 02/16/2010 | US7662948 Antisense oligonucleotides against VR1 |
| 02/16/2010 | US7662932 Endothelial growth factor; isolated polypeptide; stimulate cell proliferation, neovascularization, vascular system permeability |
| 02/16/2010 | US7662919 Notch-based fusion proteins and uses thereof |
| 02/16/2010 | US7662916 Modified HIV Env polypeptides |
| 02/16/2010 | US7662807 Sulphonated meso-tetraphenyl chlorins |
| 02/16/2010 | US7662800 Hyaluronic acid derivatives |
| 02/16/2010 | US7662796 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 |
| 02/16/2010 | US7662794 DNA enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/16/2010 | US7662793 Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from a Pol III promoter |
| 02/16/2010 | US7662791 Suppression gene expression |
| 02/16/2010 | US7662772 Methods for treating congestive heart failure |
| 02/16/2010 | US7662629 Cationic peptide scaffold conjugated to a nuclear targeting peptide through a specified hydrolysis resistant chemical linkage; use in transfection i.e. nonviral gene transfer |
| 02/16/2010 | US7662628 Method for producing a protein by culturing in culture medium a host cell transfected with a vector comprising a nucleic acid having the given nucleotide sequence; treatment of myocardial necrosis or ischemia reperfusion injuries; gene therapy; inhibits cell death associated with hypoxia, apoptosis |
| 02/16/2010 | US7662627 Adeno-associated virus materials and methods |
| 02/16/2010 | US7662622 Flea peritrophin nucleic acid molecules |
| 02/16/2010 | US7662621 a part of the interior gene is deleted, and the transgene is inserted into the gap created by the deletion; capable of expressing a desired protein in target cells. |
| 02/16/2010 | US7662620 Stem cell-derived neuron survival factor polypeptides (SDNSF) for use in prevention and treatment of cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/16/2010 | US7662608 Transgenic cell line modified to procontinuously produce budding particle for use as model in diagnostic screening and testing; drug monitoring; antitumor agents; viricides |
| 02/16/2010 | US7662591 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/16/2010 | US7662568 Used in highly specific and sensitive nucleic acid amplification assays; ability to detect biological toxins at sub-attomolar (10-18M) concentrations |
| 02/16/2010 | US7662398 Microorganisms for therapy |
| 02/16/2010 | US7662395 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 02/16/2010 | US7662394 Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence |
| 02/16/2010 | US7662392 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 02/16/2010 | US7662391 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines |
| 02/16/2010 | US7662389 Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 02/16/2010 | CA2266748C Three component chimeric antisense oligonucleotides |
| 02/16/2010 | CA2220433C Il-6 activity inhibitor |
| 02/16/2010 | CA2204254C Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand |
| 02/11/2010 | WO2010017544A2 Long-acting dna dendrimers and methods thereof |
| 02/11/2010 | WO2010017436A2 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 02/11/2010 | WO2010017264A2 Photo-crosslinked nucleic acid hydrogels |
| 02/11/2010 | WO2010016590A1 Therapeutic or prophylactic agent for generalized pain syndrome |
| 02/11/2010 | WO2010016525A1 Immunity inducer |
| 02/11/2010 | WO2010015087A1 Method of inducing stem cell differentiation |
| 02/11/2010 | WO2009154790A8 Novel metastasis suppressor genes and uses thereof |
| 02/11/2010 | WO2009003125A8 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 02/11/2010 | US20100036084 Biodegradable poly(beta-amino esters) and uses thereof |
| 02/11/2010 | US20100035975 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences |
| 02/11/2010 | US20100035973 Disruption of programmed death 1 (pd-1) ligand to adjuvant adeno-associated virus vector vaccines |
| 02/11/2010 | US20100035806 Compositions and Methods for Detection and Modulation of T Cell Mediated Immune Responses Against Viral Vectors Utilized for Gene Therapy |
| 02/11/2010 | US20100034835 Use of inhibitors of leukotriene b4 receptor blt2 for treating asthma |
| 02/11/2010 | US20100034796 Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction |
| 02/11/2010 | US20100034789 Novel carbosilane dendrimers, preparation method thereof and use of same |
| 02/11/2010 | US20100034788 Method for diagnosing and treating bone-related diseases |
| 02/11/2010 | US20100034780 Tumor antigen peptide derived from amacr |
| 02/11/2010 | US20100034776 Replication-competent anti-cancer vectors |
| 02/11/2010 | US20100034774 Serotype of adenovirus and uses thereof |
| 02/11/2010 | CA2732283A1 Immunity-inducing agent |
| 02/11/2010 | CA2731521A1 Long-acting dna dendrimers and methods thereof |
| 02/10/2010 | EP2151497A2 Chimeric U2 snRNA molecules carrying antisense sequences against the splice junctions of the dystrophin gene and their therapeutic applications |
| 02/10/2010 | EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
| 02/10/2010 | EP2151248A1 Improved pre-mRNA trans-splicing molecule (RTM) molecules and their uses |
| 02/10/2010 | EP2150618A1 Il-12 immunotherapy for cancer |
| 02/10/2010 | EP2150117A1 Methods and compositions for mitochondrial replacement therapy |
| 02/10/2010 | CN101643789A RNA interference mediating small RNA molecules |
| 02/10/2010 | CN101643732A A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 02/10/2010 | CN101642577A Application of human ING4 gene serving as radiation sensitizer |
| 02/10/2010 | CN100588708C Anti-SARS vaccine |
| 02/10/2010 | CN100588430C SARS-Cov gene vaccine based on epi-position and its contruction |
| 02/09/2010 | US7659391 Method for the in vitro synthesis of short double stranded RNAs |
| 02/09/2010 | US7659390 For modulating the expression of genes associated with respiratory and pulmonary disease, such as cholinergic muscarinic receptor genes; nucleic acids with a pyrimidine modification |
| 02/09/2010 | US7659389 RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA) |
| 02/09/2010 | US7659387 Transgenic mammals introduced a Period 1 promoter that confers rhythmical expression |
| 02/09/2010 | US7659377 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 02/09/2010 | US7659368 ErbB2 and ErbB3 chimeric heteromultimer adhesins |
| 02/09/2010 | US7659118 Multipotent adult stem cells |
| 02/09/2010 | US7659115 Nucleic acid encoding human transductin-1 polypeptide |
| 02/09/2010 | US7659114 Recombinant feline herpesvirus type 1 and polyvalent vaccine using the same |
| 02/09/2010 | US7659113 Delivery system |
| 02/09/2010 | US7659094 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/09/2010 | US7658934 Chlamydia antigens and protein vaccine |
| 02/09/2010 | US7658923 Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 02/09/2010 | CA2466372C Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 02/09/2010 | CA2407112C Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 02/09/2010 | CA2392033C Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 02/09/2010 | CA2375189C A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
| 02/09/2010 | CA2370714C Bacterial ghosts as carrier and targeting vehicles |
| 02/09/2010 | CA2235810C Senescent cell-derived inhibitors of dna synthesis |
| 02/09/2010 | CA2205910C Plasmids suitable for il-2 expression |